Affimed NV (LTS:0HL9) Other Current Liabilities : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Affimed NV Other Current Liabilities?

Affimed NV's other current liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

Affimed NV's quarterly other current liabilities declined from Jun. 2023 ($-0.00 Mil) to Sep. 2023 ($-0.00 Mil) but then increased from Sep. 2023 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil).

Affimed NV's annual other current liabilities increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil) but then stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Affimed NV Other Current Liabilities Historical Data

The historical data trend for Affimed NV's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Other Current Liabilities Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Affimed NV Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Affimed NV Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Affimed NV's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (LTS:0HL9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (LTS:0HL9) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

AFMD:USA A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Affimed NV (LTS:0HL9) Headlines

No Headlines